What if GLP-1 medications are not just changing weight loss—but completely transforming the future of women’s health?
In this special SXSW panel discussion, Shannon Ritchey moderates an eye-opening conversation with leading experts McCall McPherson, Natalie Crawford, and Jessica Shepherd about the rapidly evolving role of GLP-1 medications in fertility, thyroid health, inflammation, menopause, longevity, metabolic health, and chronic disease prevention.
This conversation goes far beyond weight loss. The panel explores how GLP-1 medications may reduce systemic inflammation, improve insulin resistance, support fertility outcomes, influence hormone health during perimenopause and menopause, protect cardiovascular health, and potentially reshape the future of longevity medicine.
The discussion also tackles common myths, cancer fears, muscle loss concerns, microdosing strategies, fertility safety, lifestyle foundations, and the importance of preserving muscle while using these medications.
🔑 Key Topics Covered
🧠 GLP-1s Are Not Just About Eating Less
One of the strongest themes throughout the panel:
👉 GLP-1 medications are not simply making people lose weight because they eat less.
According to McCall McPherson, these medications fundamentally improve:
This is especially important for women with:
The panel repeatedly emphasizes:
👉 Weight gain is often not a willpower problem—it is a metabolic and inflammatory problem.
⚡ The Emerging Power of Microdosing
A major topic discussed is microdosing GLP-1s.
What Is Microdosing?
Using:
Rather than aggressively increasing medication doses, microdosing may help:
McCall McPherson explains that many patients experience:
…even at very low doses.
🔥 Inflammation: The Hidden Driver of Disease
Throughout the panel, inflammation is described as one of the biggest underlying drivers of:
The panelists repeatedly explain that GLP-1s appear to dramatically reduce inflammation—sometimes within days.
Why This Matters
Reducing inflammation may influence:
This is one reason the panel believes GLP-1s may eventually become indicated for many conditions beyond obesity and diabetes.
🦋 Thyroid Disease, Autoimmunity & GLP-1s
McCall McPherson shares extensive clinical observations from treating thyroid patients with GLP-1s.
Key Insights Discussed
The panel also directly addresses concerns about thyroid cancer.
What Current Research Shows
The fear largely originated from rodent studies involving:
Current human data has not shown meaningful increased thyroid cancer risk.
In fact:
👉 Some studies suggest reductions in several cancer risks while using GLP-1s.
💪 Muscle Loss, Protein & Strength Training
One of the biggest concerns surrounding GLP-1s is muscle loss.
The panel makes an important distinction:
👉 Muscle loss is not inherently caused by the medication itself
👉 It is often caused by under-fueling and inadequate resistance training
The Real Problem
Some individuals:
This creates:
The Solution
According to Shannon Ritchey:
The panel strongly reinforces:
👉 Muscle is metabolic currency for women’s long-term health.
👶 Fertility, PCOS & Pregnancy
Natalie Crawford discusses the growing role of GLP-1s in fertility medicine.
Conditions Showing Promise
Why It Matters
Insulin resistance impacts:
Reducing inflammation and improving metabolic health may dramatically improve reproductive outcomes.
Important Safety Note
GLP-1s are not currently recommended during pregnancy.
Patients are advised to:
👉 Stop GLP-1 medications at least two months before attempting conception.
🌸 Perimenopause, Menopause & Hormonal Aging
Jessica Shepherd explains how declining estrogen impacts:
The panel highlights that menopause is:
👉 A whole-body hormonal transition—not just a reproductive event.
Why GLP-1s May Matter in Midlife
As estrogen declines:
GLP-1s may help:
❤️ Cardiovascular Health & Longevity
Another major theme:
👉 Cardiovascular disease remains the number one killer of women.
The panel discusses research showing GLP-1s may:
Potential Longevity Implications
Improved:
…may contribute to:
🍷 Addiction, Fatty Liver & Emerging Research
The discussion also touches on newer research areas.
Emerging Benefits Being Studied
The panel emphasizes:
👉 Research is still evolving, but the possibilities are significant.
🌱 Lifestyle Still Matters Most
Despite enthusiasm around GLP-1s, every panelist strongly reinforces:
👉 Medication is not a replacement for lifestyle.
Foundational habits remain critical:
The medications work best when paired with:
👉 Sustainable lifestyle change.
🌟 Final Takeaway
This SXSW discussion makes one thing very...